Precigen, Inc. (PGEN)
Precigen Market Cap : 1.578B for Nov. 18, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 17, 2026 | 1.538B |
| November 16, 2026 | 1.542B |
| November 13, 2026 | 1.628B |
| November 12, 2026 | 1.671B |
| November 11, 2026 | 1.692B |
| November 10, 2026 | 1.621B |
| November 09, 2026 | 1.696B |
| November 06, 2026 | 1.603B |
| November 05, 2026 | 1.513B |
| November 04, 2026 | 1.812B |
| November 03, 2026 | 1.882B |
| November 02, 2026 | 1.843B |
| October 30, 2026 | 2.485B |
| October 29, 2026 | 2.377B |
| October 28, 2026 | 2.177B |
| October 27, 2026 | 2.202B |
| October 26, 2026 | 2.162B |
| October 23, 2026 | 2.216B |
| October 22, 2026 | 2.288B |
| October 21, 2026 | 2.363B |
| October 20, 2026 | 2.445B |
| October 19, 2026 | 2.384B |
| October 16, 2026 | 2.286B |
| October 15, 2026 | 2.576B |
| October 14, 2026 | 2.633B |
| Date | Value |
|---|---|
| October 13, 2026 | 2.678B |
| October 12, 2026 | 2.742B |
| October 09, 2026 | 2.796B |
| October 08, 2026 | 2.721B |
| October 07, 2026 | 2.699B |
| October 06, 2026 | 2.703B |
| October 05, 2026 | 2.771B |
| October 02, 2026 | 3.057B |
| October 01, 2026 | 2.939B |
| September 30, 2026 | 3.065B |
| September 29, 2026 | 2.882B |
| September 28, 2026 | 2.796B |
| September 25, 2026 | 2.775B |
| September 24, 2026 | 2.757B |
| September 23, 2026 | 2.664B |
| September 22, 2026 | 2.825B |
| September 21, 2026 | 2.757B |
| September 18, 2026 | 2.785B |
| September 17, 2026 | 2.818B |
| September 16, 2026 | 2.662B |
| September 15, 2026 | 2.506B |
| September 14, 2026 | 2.452B |
| September 11, 2026 | 2.452B |
| September 10, 2026 | 2.391B |
| September 09, 2026 | 2.434B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Anika Therapeutics, Inc. | 177.20M |
| Aldeyra Therapeutics, Inc. | 40.46M |
| Repligen Corp. | 9.712B |
| AC Immune SA | 189.49M |
| Inovio Pharmaceuticals, Inc. | 174.09M |
Market Cap Related Metrics
| PE Ratio | 98.65 |
| PS Ratio | 10.82 |
| Price to Book Value | 18.83 |
| Price | 4.40 |
| Earnings Yield | 1.01% |
| Operating PE Ratio | 50.47 |
| Normalized PE Ratio | 98.65 |